Anomer Bio
Anomer Bio: Glycan-targeted small molecule drugs to tackle disease at its first layer of interaction
About Anomer Bio
Anomer Bio is a company based in London, United Kingdom. Recent Funding lists it under Health and bio. It went through IndieBio (IndieBio NY 2025 H2). Investors on record for it include SOSV and SOSV SF & NY (Fka IndieBio). It was founded by Sophie James, Marcos Burger Ramos and Oliver Pearce.
Funding rounds
- Website created
- IndieBio NY 2025 H2
IIndieBio · batchSource: indiebio.co
Founders and team
SJ
Sophie James Co-founder and CEOLinkedIn · source: anomer.bio- MBMarcos Burger Ramos Co-founder and CSOsource: anomer.bio
- OPOliver Pearce Scientific co-founder and advisorsource: anomer.bio
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
Anomer Bio: questions and answers
- Who invested in Anomer Bio?
- Investors on record for Anomer Bio: IndieBio, SOSV and SOSV SF & NY (Fka IndieBio).
- Who founded Anomer Bio?
- Anomer Bio was founded by Sophie James (Co-founder and CEO), Marcos Burger Ramos (Co-founder and CSO) and Oliver Pearce (Scientific co-founder and advisor).
- Where is Anomer Bio based?
- Anomer Bio is based in London, United Kingdom.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/anomer-bio (get a free API key).